Eurosan en es it fr

Eurosan Brand names, Eurosan Analogs

Eurosan Brand Names Mixture

  • No information avaliable

Eurosan Chemical_Formula


Eurosan RX_link

Eurosan fda sheet

Eurosan msds (material safety sheet)

Eurosan MSDS

Eurosan Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Eurosan Molecular Weight

284.74 g/mol

Eurosan Melting Point


Eurosan H2O Solubility

Slightly soluble (50 mg/L)

Eurosan State


Eurosan LogP


Eurosan Dosage Forms

Tablets; Injectable solution

Eurosan Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Eurosan Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Eurosan Absorption

Essentially complete, with a bioavailability of 93%.

Eurosan side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Eurosan Patient Information

Eurosan Organisms Affected

Humans and other mammals